NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$0.58
0.02 (4.45%)
▲
5d:
-0.7%
30d:
-52.34%
90d:
-48.08%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$3.39
82.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $0.58, which is considered oversold relative to its 30-day fair value range of $0.62 to $1.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.0) compared to its historical average (0.1). Remarkably, the market is currently pricing in an annual earnings decline of 46.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $0.70. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: NIVF scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $42.36 (+7184.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NIVF is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $0.70. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: NIVF scores 84/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $42.36 (+7184.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.62 -
$1.29
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (84/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 7184.6% below Wall St target ($42.36)
- CAUTION: Bottoming setup, but lagging the sector by 47% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.62 -
$1.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.45
Resistance Level
$0.70
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.02
Wall Street Target
$42.36
(+7184.6%)
Revenue Growth (YoY)
11.9%
Profit Margin
209.0%
Valuation Discount vs History
-46.9% cheaper
PE vs Historical
0.0 vs 0.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-46.9%
(market-implied from PE analysis)
1-Year Target
$0.52
(-10%)
2-Year Target
$0.47
(-19%)
3-Year Target
$0.42
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$2.04
(+251%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 97.0%)
$1897.97
(+326292%)
Base:
(SPY PE: 0.0, Growth: 97.0%)
$1.96
(+238%)
Bear:
(PE: 0.0, Growth: 97.0%)
$1.67
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 0.01 | Current EPS (TTM): $108.08
Bull Case
$0.31
(-47%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.28
(-52%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$0.38
(-34%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.0 to 0.1
Stabilization Target:
$2.80
(+381.9%)
PE Expansion Potential:
+381.9%
Share & Embed Analysis
Last updated: August 22, 2026 8:33 PM ET
Data refreshes hourly during market hours. Next update: 9:33 PM
Data refreshes hourly during market hours. Next update: 9:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
